Dr. Kris Discusses Tests Available for Lung Cancer

Mark G. Kris, MD
Published: Tuesday, Jun 28, 2011

Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.

Dr. Kris says the vast majority of tests are for mutations. He says FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.
Mark G. Kris, MD, the chief of Thoracic Oncology Service at Memorial Sloan-Kettering Cancer Center discusses tests available for lung cancer patients.

Dr. Kris says the vast majority of tests are for mutations. He says FISH is a poor cousin of mutation and that virtually all mutated patients are FISH positive. Tests for mutations are more potent predictors and most trials use them. Some of the tests are done by FISH test. They look for MET amplifications and EML4-ALK as a FISH test.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Updates in Novel Therapeutic Options for Lung Neuroendocrine TumorsMay 31, 20181.0
Community Practice Connections™: Working Group to Optimize Outcomes in EGFR-mutated Lung Cancers: Evolving Concepts for Nurses to Facilitate and Improve Patient CareJun 30, 20181.5
Publication Bottom Border
Border Publication
x